Aspen Neuroscience is a clinical-stage biotechnology company developing personalized regenerative cell therapies for Parkinson's disease. Its lead candidate, ANPD001, is an autologous induced pluripotent stem cell (iPSC)-derived neuron replacement therapy that uses a patient's own cells to restore dopamine function without requiring… - View it on GitHub